Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Antiandrogen therapy helps treat genetic hair loss.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Taxifolin from Rhododendron mucronulatum may help prevent hair loss and promote hair growth.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Chicken feather gene mutation helps understand human hair disorders.

Aromatase gene variation may increase female hair loss risk.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Vitamin D3 analogs can promote hair growth in mice genetically prone to hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Water extract of Cacumen Platycladi helps hair growth by activating specific cell pathways.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.